Abstract
Long-Term Effect of Ruxolitinib (RUX) in Inadequately Controlled Polycythemia Vera (PV) without Splenomegaly: 5-Year Results from the Phase 3 Response-2 Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have